None of the patients showed any other indicators of liver disorders. Other biochemistry ideals in the two treatment groups were very similar. Key laboratory ideals are shown in Table 10 and Table 11 in the Supplementary Appendix. Six individuals in the mefloquine-plus-artesunate group. All abnormalities were mild and resolved before study completion. Of those individuals, one in the group receiving mefloquine plus artesunate had an extended or prolonged QT interval. None got a QT interval that exceeded 480 msec. Falciparum malaria.7 percent versus 1.2 percent .10 This difference can be attributed to the higher immunity to P probably.I’m really concerned about this. Unfortunately a lot of people when I’ve spoken to them about Adya, they don’t seem to understand that this is an extremely serious thing. I simply spoke with someone yesterday who had an individual, and she said wow, I have a patient who’s taking this at this time, and she’s pregnant, and she just got immediately – – oh my god – – and she immediately started texting this girl, please stop taking that right now. Because the implications were realized by her. But many people don’t understand the implications. They don’t really know that the fetal human brain is so much more susceptible and vulnerable.